ENDRA Life Sciences (NDRA) Return on Capital Employed (2017 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Return on Capital Employed of 230.12% for Q1 2026, up 49634.0% year-over-year from N/an in Q1 2025, and up 43.24% quarter-over-quarter from 405.39% in Q4 2025.
ENDRA Life Sciences (NDRA) Return on Capital Employed (2017 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Return on Capital Employed for 10 consecutive years, with 230.12% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed rose 49634.0% year-over-year to 230.12%; the TTM figure through Mar 2026 stood at 230.12% (up 49634.0% YoY), while the FY2025 annual figure was 393.4%, down 4000.0% from the prior year.
- Return on Capital Employed advanced to 230.12% in Q1 2026 per NDRA's latest filing, from 405.39% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 5372.63% in Q4 2024 and bottomed at 993.61% in Q3 2025.
- Historically, Return on Capital Employed has averaged 50.09% across 5 years, with a median of 197.88% in 2023.
- Annual changes were most pronounced in 2024 — Return on Capital Employed jumped 554028 bps — and 2025, when it sank 577802 bps.
- ENDRA Life Sciences' Return on Capital Employed stood at 144.51% in 2022, then retreated by 16 bps to 167.65% in 2023, then jumped by 3305 bps to 5372.63% in 2024, then plunged by 108 bps to 405.39% in 2025, then surged by 43 bps to 230.12% in 2026.
- Business Quant data shows NDRA's Return on Capital Employed at 230.12% in Q1 2026, 405.39% in Q4 2025, and 993.61% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 8.30% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 6.42% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 68.60% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 14.57% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 10.49% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -16.64% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 17.55% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 49.80% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.85% |
| 10 | ENDRA Life Sciences | 5.44 Mn | 5.08 Mn | - | -230.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -230.12% |
| Dec 31, 2025 | -405.39% |
| Sep 30, 2025 | -993.61% |
| Jun 30, 2025 | -355.49% |
| Mar 31, 2025 | -726.46% |
| Dec 31, 2024 | 5,372.63% |
| Sep 30, 2024 | -176.43% |
| Jun 30, 2024 | -149.94% |
| Mar 31, 2024 | -220.90% |
| Dec 31, 2023 | -167.65% |
| Sep 30, 2023 | -197.88% |
| Jun 30, 2023 | -214.04% |
| Mar 31, 2023 | -215.92% |
| Dec 31, 2022 | -144.51% |
| Sep 30, 2022 | -106.56% |
| Jun 30, 2022 | -104.55% |
| Mar 31, 2022 | -111.66% |
| Dec 31, 2021 | -91.62% |
| Sep 30, 2021 | -72.65% |
| Jun 30, 2021 | -68.68% |